$ALXN Recent News S&P 500 ekes out another rec
Post# of 144491
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 3:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 4:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 9:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 5:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 4:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 4:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
U.S. stocks fall amid China worries 4:20 p.m. March 10, 2014 - Anora Mahmudova
Stock Market News for August 15, 2014 - Market News 10:10 a.m. Aug. 15, 2014 - Zacks.com
Alexion CEO Receives Nearly 17 Million for Sale of Company Stock 3:02 p.m. Aug. 14, 2014 - GuruFocus.com
Biggest Movers in Healthcare Stocks Now – ALXN ACT TEVA WST 2:00 p.m. Aug. 14, 2014 - InvestorPlace.com
Stock Market News for August 14, 2014 - Market News 10:10 a.m. Aug. 14, 2014 - Zacks.com
12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds 10:54 a.m. Aug. 10, 2014 - Seeking Alpha
Alnylam Pharmaceuticals Has Plenty On Its Plate 10:36 a.m. Aug. 9, 2014 - Seeking Alpha
Utilities Help Stocks Edge Up on Week 2:29 a.m. Aug. 9, 2014 - Barrons.com
GW Pharma, Insys Face Off In Cannabis Drug Space 3:45 p.m. Aug. 8, 2014 - Investors Business Daily
Today's Stocks Driving Success For The Health Care Sector 1:03 p.m. Aug. 8, 2014 - TheStreet.com
VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog 11:00 a.m. Aug. 8, 2014 - Zacks.com
Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog 9:20 a.m. Aug. 8, 2014 - Zacks.com
Here's How Facebook, Alexion Teach Lessons In Tenacity 5:02 p.m. Aug. 7, 2014 - Investors Business Daily
NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog 12:40 p.m. Aug. 7, 2014 - Zacks.com
Vertex's Price And Prospects Compared To Alexion 10:50 a.m. Aug. 7, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ACAD CNC RMD LCI 2:00 p.m. Aug. 6, 2014 - InvestorPlace.com
Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook - Analyst Blog 2:00 p.m. Aug. 5, 2014 - Zacks.com
Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog 3:40 p.m. Aug. 4, 2014 - Zacks.com
3 Health Care Stocks Dragging The Sector Down 1:03 p.m. Aug. 4, 2014 - TheStreet.com
Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog 11:10 a.m. Aug. 4, 2014 - Zacks.com
4 Biotech Stocks to Buy 6:35 a.m. Aug. 4, 2014 - InvestorPlace.com
Technical Updates, Study Outcomes, Project Approvals, and Quarterly Performance Reviews - Research Reports on Alexion, Novartis, CB&I, L-3 and Emerson 8:40 a.m. Aug. 15, 2014 - PR Newswire - PRF
Researchers to Present New Data on Asfotase Alfa in Pediatric Patients with Hypophosphatasia at the American Society for Bone and Mineral Research 2014 Annual Meeting 4:57 p.m. Aug. 13, 2014 - BusinessWire - BZX
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 2:44 p.m. Aug. 11, 2014 - ACCESSWIRE
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF
Financial Results, FDA Approvals, Orphan Drug Designations, and Certificates - Research Reports on Idenix, Baxter, Alexion, Alere and Zoetis 9:10 a.m. Aug. 7, 2014 - PR Newswire - PRF
European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG) 6:30 a.m. Aug. 1, 2014 - BusinessWire - BZX
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:15 a.m. July 24, 2014 - BusinessWire - BZX
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF
Alexion Announces the Appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to Its Board of Directors 8:02 a.m. July 16, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Second Quarter 2014 Results on Thursday, July 24, 2014 10:00 a.m. July 10, 2014 - BusinessWire - BZX
Market Activity and Upcoming Quarterly Results - Analyst Notes on Bristol-Myers Squibb, Abbott, Alexion, Mallinckrodt and Baxter 6:10 a.m. July 8, 2014 - PR Newswire - PRF
Raptor Announces CEO Succession Plan; Dr. Christopher Starr to Retire as CEO at Year-end 2014, Julie Anne Smith Named President and CEO-Designate 4:02 p.m. July 7, 2014 - GlobeNewswire
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 5:55 a.m. July 7, 2014 - PR Newswire - PRF
Conference Call Schedules, Disclosures, Partnerships, and Acquisitions - Analyst Notes on Pfizer, Covidien, UnitedHealth Group, Alexion and Abbott 5:50 a.m. June 27, 2014 - PR Newswire - PRF
Alexion and Cincinnati Children’s Launch Rare Disease Innovation Fund 6:30 a.m. June 23, 2014 - BusinessWire - BZX
FDA Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG) 6:39 a.m. June 17, 2014 - BusinessWire - BZX
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 5:50 a.m. June 11, 2014 - PR Newswire - PRF
Critical Alerts For Apple, Orexigen Therapeutics, NextEra Energy, Family Dollar Store, and Alexion Pharmaceuticals Technology Released By InvestorsObserver 9:31 a.m. June 10, 2014 - PR Newswire - PRF
Biotech Equities under the Scanner -- Research on Halozyme Therapeutics, Medivation, Achillion Pharma, and Alexion Pharma 8:10 a.m. June 6, 2014 - PR Newswire - PRF